missing translation for 'onlineSavingsMsg'
Learn More

Novus Biologicals™ LIR-6/LILRA1 Antibody (4A1E10A6), Novus Biologicals™

Mouse Monoclonal Antibody

Brand:  Novus Biologicals™ NBP3-27141-0.1ml

 View more versions of this product

Product Code. 30028594

  • 534.00€ / 0.10mL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

LIR-6/LILRA1 Monoclonal antibody specifically detects LIR-6/LILRA1 in Human samples. It is validated for Flow Cytometry,ELISA,Western Blot
TRUSTED_SUSTAINABILITY
Specifications

Specifications

LIR-6/LILRA1
Monoclonal
1 mg/mL
Western Blot 1:500 - 1:2000, Flow Cytometry 1:200 - 1:400, ELISA 1:10000
CD85 antigen-like family member I, CD85i, CD85i antigen, leukocyte immunoglobulin-like receptor subfamily A member 1, leukocyte immunoglobulin-like receptor subfamily A member 1 soluble isoform, leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 1, LIR-6Leukocyte immunoglobulin-like receptor 6, LIR6MGC126563
Purified recombinant fragment of human LIR-6/LILRA1 (AA: extra 322-461) expressed in E. Coli.
0.1 mL
Primary
Human
Purified
Flow Cytometry, ELISA, Western Blot
4A1E10A6
Unconjugated
PBS
Mouse
Protein G purified
RUO
11024
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
IgG2a
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.